T. Rowe Price Associates’s Elanco Animal Health ELAN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.64M | Sell |
|
|||||
|
2025
Q1 | $4.22M | Sell |
|
|||||
|
2024
Q4 | $6.74M | Sell |
|
|||||
|
2024
Q3 | $44.6M | Sell |
|
|||||
|
2024
Q2 | $405M | Buy |
|
|||||
|
2024
Q1 | $360M | Buy |
|
|||||
|
2023
Q4 | $317M | Buy |
|
|||||
|
2023
Q3 | $224M | Buy |
|
|||||
|
2023
Q2 | $175M | Buy |
|
|||||
|
2023
Q1 | $163M | Sell |
|
|||||
|
2022
Q4 | $228M | Sell |
|
|||||
|
2022
Q3 | $335M | Buy |
|
|||||
|
2022
Q2 | $435M | Sell |
|
|||||
|
2022
Q1 | $900M | Buy |
|
|||||
|
2021
Q4 | $978M | Sell |
|
|||||
|
2021
Q3 | $1.5B | Buy |
|
|||||
|
2021
Q2 | $1.62B | Buy |
|
|||||
|
2021
Q1 | $1.23B | Buy |
|
|||||
|
2020
Q4 | $1.27B | Buy |
|
|||||
|
2020
Q3 | $1.15B | Sell |
|
|||||
|
2020
Q2 | $984M | Sell |
|
|||||
|
2020
Q1 | $1.04B | Buy |
|
|||||
|
2019
Q4 | $983M | Sell |
|
|||||
|
2019
Q3 | $990M | Sell |
|
|||||
|
2019
Q2 | $1.43B | Buy |
|
|||||
|
2019
Q1 | $1.24B | Buy |
|
|||||
|
2018
Q4 | $89.4M | Buy |
|
|||||
|
2018
Q3 | $98.3M | Buy |
|